Financing, Equity Capital Markets

Talis Biomedical

02/21
|
$253.9 Million
Piper Sandler served as bookrunner for Talis Biomedical Corporation on its initial public offering
Sub-Type
IPO
Sub-Sector
Tools & Diagnostics